Researchers at Emory University received $5.1 million in life science research funding from the NIH this past June. The title of the project receiving funding is “B-Cell Biology of Mucosal Immune Protection from SIV Challenge,” and the project leader is Eric Hunter, PhD. Dr. Hunter’s area of expertise is HIV/AIDS. According to the Emory University webpage, his research focuses on understanding virus-cell interactions, how independently targeted capsid and glycoprotein molecules are brought to the assembly site, what pathways are used, and what roles cell- and virus- encoded gene products assume while this is going on. The NIH RePORTER provides more information on the project receiving $5.1 million in life science funding:
“The development of a safe and effective vaccine against HIV-1 is critical for curtailing the spread of a primarily sexually transmitted disease that is now affecting more than 30 million persons worldwide. While a recent poxvirus-protein immunogen efficacy trial conferred modest protection from acquisition, the correlates of protection are unknown. In the SIV infection model in Rhesus macaques, up to 70% of animals, vaccinated with GM-CSF enhanced DNA priming, MVA boosted, then subjected to a heterologous (E660), multiple low dose rectal challenge, were protected from acquisition and a clear correlate of protection was E660 Env binding antibody avidity. The Emory Consortium for B-Cell Biology of Mucosal Immune Protection from SIV Challenge, using highly collaborative approaches, will define through advanced immunological and systems biology approaches the underlying mechanisms for enhanced antibody avidity and protection.”
Atlanta BioResearch Product Faire™ Event 2013
In addition to receiving $5.1 million from the NIH, Emory University receives a great deal of additional life science research funding from the NIH and NSF. In 2012, Emory University received $296.8 million in life science funding from the NIH and NSF. The NIH awarded Emory University $286.2 million in life science research funding in 2012. Emory University’s 2011 NIH ranking was 18th in the country for direct plus indirect costs in the life sciences, excluding R&D contracts and ARRA awards. The total costs were $273.4 million. For a full list of NIH-funded departments at Emory University, please visit the NIH website.
In addition to receiving $286.2 million of life science funding from the NIH, Emory University also received $10.6 million from the NSF in 2012. In 2010, the NSF also ranked Emory University 25th in the country for total R&D expenditures in the life sciences. Emory’s total expenditures in 2010 were $399.1 million.
If you are a lab supplier interested in networking with researchers, lab managers and purchasing agents at life science marketing events in Atlanta, Biotechnology Calendar, Inc. invites you to attend our Atlanta BioResearch Product Faire™ Event. Last year, the Atlanta BioResearch Product Faire™ Event attracted 213 attendees. Of those who came, 58 were purchasing agents, professors and post docs, and 30 were lab managers. The attendees came from 34 different research buildings and 55 departments around campus.
Biotechnology Calendar, Inc. is a full-service science research marketing and events-planning company that organizes life science marketing events at top research institutions nationwide. If you’re interested in meeting researchers at life science marketing events closer to home, we encourage you to view our 2013 calendar of events. For more life science funding statistics about Emory University, or to learn more about the Atlanta BioResearch Product Faire™ Event, click on the button below.
